Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02968264 · ClinicalTrials.gov registry record
Tetralogy of Fallot for Life
A clinical trial, sponsored by Population Health Research Institute.
- Completed
- Registry status
- 1,108
- Enrollment target
NCT02968264: Completed study, sponsored by Population Health Research Institute.
NCT02968264 is a clinical trial that has completed, run by Population Health Research Institute. The registered enrollment target is 1,108 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02968264 has completed, sponsored by Population Health Research Institute.
- COMPLETED
- Registry status
- 1,108 participants
- Enrollment target
Study Summary
The aim is to conduct a prospective multi-centre international inception cohort study with an enrollment goal of 3,000 TOF patients and 2 year follow-up post-repair. The proposed sample size and methodology will result in statistically powerful results to allow for evidence-based change to current TOF surgical practices.
Primary Outcome
To determine the association between baseline morphology, surgical repair technique (various surgical strategies for VSD closure and managing the RVOT), and RV physiology and morphology at 2 years obtained from echocardiogram studies.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,108 participants |
| Start Date | 2015-06-08 |
| Est. Completion | 2022-07-01 |
What the finished NCT02968264 record still lists
NCT02968264 is an observational study that tracks outcomes without assigning an intervention. Its 1,108 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT02968264 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02968264 about?
NCT02968264 is a clinical study titled "Tetralogy of Fallot for Life". The aim is to conduct a prospective multi-centre international inception cohort study with an enrollment goal of 3,000 TOF patients and 2 year follow-up post-repair. The proposed sample size and methodology will result in statistically powerful results to allow for evidence-based change to current T...
What is the current status of trial NCT02968264?
This trial is currently completed. The enrollment target is 1,108 participants. The study started on 2015-06-08. Estimated completion is 2022-07-01.
Who is sponsoring clinical trial NCT02968264?
This trial is sponsored by Population Health Research Institute, which has 21 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00710112 · 1,100 participants
Genetic Variants and Susceptibility to Diseases of Prematurity in Very Low Birth-Weight Infants
- NCT02688517 · 1,100 participants
Targeted Genomic Analysis of Blood and Tissue Samples From Patients With Cancer
- NCT04743765 · 1,100 participants · NA
HIP Fracture Accelerated Surgical TreaTment And Care tracK 2 Trial
- NCT05638581 · 1,100 participants · Phase 3
Trauma Resuscitation With Low-Titer Group O Whole Blood or Products
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI